The role of drug use sequencing pattern in further problematic use of alcohol, tobacco, cannabis, and other drugs
Carregando...
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Autores
MARTINS, Silvia S.
NICASTRI, Sergio
Citação
JOURNAL OF MENTAL HEALTH, v.24, n.1, p.9-14, 2015
Resumo
Background: There has been considerable debate regarding what typically occurs after experimentation with drugs throughout the life of young people who used various drugs. Aims: To evaluate the clinical importance of the most common sequence for the first use of a drug by two models (the ""gateway model'' and the ""alternative model'', which is the most popular sequence for Brazilian university students according to a previous study) regarding the problematic use of alcohol, tobacco, cannabis and other illegal drugs, assessed by ASSIST. Method: People who had already experimented with three or more drugs across different stages of the two models were selected from a representative sample of university students from 27 Brazilian capitals (n = 12 711). Findings: There were no differences regarding the problematic use of the most consumed drugs in Brazil (alcohol, tobacco and cannabis) between the models. Multiple drug seekers and violators had more problematic use of illegal drugs other than cannabis than individuals in the model sequence. However, in the case of violators, this was only evident in the alternative model. Conclusions: Multiple drug seekers and violators deserve special attention due to their increased risk of problematic use of other illegal drugs.
Palavras-chave
Abuse, dependence, problematic use, sequence of drug experimentation, university students
Referências
- Andrade Arthur Guerra De, 1997, Revista ABP-APAL (Associacao Brasileira de Psiquiatria-Asociacion Psiquiatrica de la America Latina), V19, P53
- Caris L, 2009, DRUG ALCOHOL DEPEN, V102, P30, DOI 10.1016/j.drugalcdep.2008.12.004
- Castaldelli-Maia JM, 2014, SOC PSYCH PSYCH EPID, V49, P385, DOI 10.1007/s00127-013-0748-1
- Castaldelli-Maia JM, 2014, EXP CLIN PS IN PRESS
- Chen WJ, 2009, BMC PUBLIC HEALTH, V9, P2
- Degenhardt L, 2010, DRUG ALCOHOL DEPEN, V108, P84, DOI 10.1016/j.drugalcdep.2009.12.001
- Degenhardt L, 2009, PSYCHOL MED, V39, P157, DOI 10.1017/S0033291708003425
- Fergusson DM, 2006, ADDICTION, V101, P556, DOI 10.1111/j.1360-0443.2005.01322.x
- Fonseca AM, 2010, CIENC SAUDE COLETIVA, V15, P663, DOI 10.1590/S1413-81232010000300008
- Henrique Iara Ferraz Silva, 2004, Rev Assoc Med Bras, V50, P199, DOI 10.1590/S0104-42302004000200039
- Herrera-Vazquez M, 2004, SALUD PUBLICA MEXICO, V46, P132, DOI 10.1590/S0036-36342004000200007
- KANDEL D, 1975, SCIENCE, V190, P912, DOI 10.1126/science.1188374
- Levine A, 2011, SCI TRANSL MED, V3, P107
- Makanjuola VA, 2010, SUBST USE MISUSE, V45, P1558, DOI 10.3109/10826081003682081
- Mayet A, 2010, ADDICT BEHAV, V35, P890, DOI 10.1016/j.addbeh.2010.06.001
- Morral AR, 2002, ADDICTION, V97, P1509, DOI 10.1046/j.1360-0443.2002.00297.x
- Parahyba MI, 2008, CIENC SAUDE COLETIVA, V13, P1257, DOI 10.1590/S1413-81232008000400022
- Posada-Villa Jose A, 2009, Rev Salud Publica (Bogota), V11, P406, DOI 10.1590/S0124-00642009000300009
- Stempliuk VD, 2005, REV BRAS PSIQUIATR, V27, P185, DOI 10.1590/S1516-44462005000300006
- Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7
- Tarter RE, 2012, DRUG ALCOHOL DEPEN, V123, pS72, DOI 10.1016/j.drugalcdep.2012.01.015
- Van Etten ML, 1997, DRUG ALCOHOL DEPEN, V49, P1, DOI 10.1016/S0376-8716(97)00127-0
- Vaughn M, 2008, AM J DRUG ALCOHOL AB, V34, P782, DOI 10.1080/00952990802455477
- Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065
- Wagner FA, 2002, AM J EPIDEMIOL, V155, P918, DOI 10.1093/aje/155.10.918
- Wagner GA, 2007, REV BRAS PSIQUIATR, V29, P123, DOI 10.1590/S1516-44462006005000033
- Wells JE, 2008, J STUD ALCOHOL DRUGS, V69, P789
- Yang LJ, 2009, AM J DRUG ALCOHOL AB, V35, P445, DOI 10.3109/00952990903469299